FDAnews
www.fdanews.com/articles/86922-baxter-and-jerini-advance-program-to-develop-non-intravenous-hemophilia-therapy

BAXTER AND JERINI ADVANCE PROGRAM TO DEVELOP NON-INTRAVENOUS HEMOPHILIA THERAPY

May 18, 2006

Baxter AG and Jerini AG today announced progress in their collaborative research program to develop a non-intravenous therapy for the treatment of hemophilia. Extensive in vitro and in vivo analyses have identified several synthetic lead molecules with promising pharmacological properties.
Europa Press